HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ali Salanti Selected Research

Chondroitin Sulfates (Chondroitin Sulfate)

12/2021The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility.
9/2021Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer.
1/2021Development of a bispecific immune engager using a recombinant malaria protein.
1/2021Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding.
1/2021The Development, Fine Specificity, and Importance of High-Avidity Antibodies to VAR2CSA in Pregnant Cameroonian Women Living in Yaoundé, an Urban City.
12/2020An affinity chromatography and glycoproteomics workflow to profile the chondroitin sulfate proteoglycans that interact with malarial VAR2CSA in the placenta and in cancer.
3/2020Optimization of rVAR2-Based Isolation of Cancer Cells in Blood for Building a Robust Assay for Clinical Detection of Circulating Tumor Cells.
1/2020A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine.
10/2019Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between Plasmodium vivax PvDBP and Plasmodium falciparum VAR2CSA.
1/2019Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ali Salanti Research Topics

Disease

84Malaria
06/2022 - 07/2003
21Infections
12/2021 - 01/2008
17Neoplasms (Cancer)
01/2022 - 10/2015
8Falciparum Malaria (Plasmodium falciparum Malaria)
01/2021 - 01/2003
3Circulating Neoplastic Cells
06/2022 - 01/2018
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2017
2COVID-19
12/2021 - 10/2021
2Human Influenza (Influenza)
07/2020 - 01/2017
2Neoplasm Metastasis (Metastasis)
01/2020 - 10/2015
2Noncommunicable Diseases
01/2018 - 04/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2021
1Type I Syndactyly
10/2019
1Papillomavirus Infections
01/2019
1Glioma (Gliomas)
01/2019
1Parasitemia
01/2018
1Carcinoma (Carcinomatosis)
01/2018
1Anemia
01/2018
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2017
1Acquired Immunodeficiency Syndrome (AIDS)
12/2016
1Parasitic Diseases (Parasitic Disease)
11/2016
1Hypersensitivity (Allergy)
04/2016
1Choriocarcinoma
01/2016
1Birth Weight (Birth Weights)
05/2015
1Premature Birth (Birth, Premature)
05/2015
1Inflammation (Inflammations)
04/2012

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
06/2022 - 02/2008
30Chondroitin Sulfates (Chondroitin Sulfate)IBA
12/2021 - 07/2003
25VaccinesIBA
12/2021 - 07/2006
24AntibodiesIBA
01/2021 - 11/2004
21AntigensIBA
01/2021 - 06/2008
10Immunoglobulin G (IgG)IBA
10/2021 - 06/2007
10Proteoglycans (Proteoglycan)IBA
09/2021 - 10/2008
8GlycosaminoglycansIBA
12/2021 - 07/2003
7ChondroitinIBA
12/2021 - 07/2003
7EpitopesIBA
07/2020 - 11/2006
7Surface Antigens (Surface Antigen)IBA
04/2012 - 07/2003
5Plasmodium falciparum erythrocyte membrane protein 1IBA
10/2021 - 12/2006
4LigandsIBA
01/2021 - 01/2016
2Epithelial Cell Adhesion MoleculeIBA
06/2022 - 01/2018
2Chondroitin Sulfate ProteoglycansIBA
01/2022 - 12/2020
2Messenger RNA (mRNA)IBA
11/2021 - 01/2009
2CarbohydratesIBA
01/2021 - 01/2020
2Hemagglutinins (Hemagglutinin)IBA
07/2020 - 01/2017
2Indicators and Reagents (Reagents)IBA
03/2020 - 01/2017
2pyrimethamine drug combination fanasil (Fansidar)FDA Link
01/2020 - 01/2013
2Monoclonal AntibodiesIBA
01/2019 - 01/2018
2Malaria VaccinesIBA
01/2017 - 11/2016
2CytokinesIBA
01/2017 - 09/2016
2Recombinant ProteinsIBA
01/2017 - 11/2016
2Biomarkers (Surrogate Marker)IBA
07/2016 - 06/2007
2Immune Sera (Antisera)IBA
10/2011 - 04/2005
1LectinsIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1AcetylgalactosamineIBA
12/2021
1NanovaccinesIBA
10/2021
1Polysaccharides (Glycans)IBA
01/2021
1Single-Chain AntibodiesIBA
01/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
07/2020
1Collodion (Nitrocellulose)IBA
01/2020
1EmulsionsIBA
10/2019
1Aluminum Hydroxide (Algeldrate)FDA Link
10/2019
1saponin QA-21V1 (QS21)IBA
10/2019
1LipidsIBA
10/2019
1Virulence Factors (Pathogenicity Factors)IBA
10/2019
1Immunodominant EpitopesIBA
10/2019
1Peptides (Polypeptides)IBA
10/2019
1Carrier Proteins (Binding Protein)IBA
01/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1Epidermal Growth Factor (EGF)IBA
01/2018
1SugarsIBA
01/2017
1chondroitin sulfate proteoglycan 4IBA
01/2017
1Cisplatin (Platino)FDA LinkGeneric
01/2017
1IntegrinsIBA
12/2016
1chondroitin sulfate glycosaminoglycanIBA
12/2016
1src-Family KinasesIBA
12/2016
1Interleukin-10 (Interleukin 10)IBA
09/2016
1ParaffinIBA
07/2016
1Formaldehyde (Formol)FDA Link
07/2016
1AutoantigensIBA
04/2016
1Syndecan-1 (Syndecan 1)IBA
01/2016
1Diphtheria ToxinIBA
10/2015
1hemiasterlinIBA
10/2015
1Immunoglobulin FragmentsIBA
01/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
02/2013
1Plasmodium falciparum VAR2CSA proteinIBA
07/2012
1Complement System Proteins (Complement)IBA
06/2012
1Histidine (L-Histidine)FDA Link
06/2012
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2012
1Immunoglobulin M (IgM)IBA
05/2010
1Fluorescent Dyes (Fluorescent Probes)IBA
06/2008
1TrypsinIBA
09/2007
1ImmunosorbentsIBA
12/2006
1EnzymesIBA
12/2006

Therapy/Procedure

8Therapeutics
01/2022 - 09/2010
1Immunotherapy
11/2021
1Intramuscular Injections
10/2019
1Drug Therapy (Chemotherapy)
01/2017
1Neoadjuvant Therapy
01/2017
1Insecticide-Treated Bednets
03/2016
1Lasers (Laser)
06/2008